Daniel Amen
Dr. Daniel Amen is a researcher and author working in the field of neuroimaging and psychiatric health. His published research focuses primarily on using brain single-photon emission computed tomography (SPECT) imaging to assess regional cerebral blood flow and neural connectivity. His work investigates functional brain imaging biomarkers across psychiatric and neurological conditions, including major depressive disorder, schizophrenia, ADHD, cognitive disorders, and the effects of adverse childhood experiences.
60 claims checked on air: 7 context 2 contradicted 6 overstated 36 supported 9 unverified
What they said on air - supported
8 citing their own research
Social isolation is a risk factor for dementia.
"isolation is actually a risk factor for dementia" (said at 0:17:09)
Large-scale systematic reviews, meta-analyses, and umbrella reviews of prospective longitudinal cohort studies confirm that social isolation (along with loneliness and low social engagement) is an established modifiable risk factor for incident dementia, associated with an approximately 1.5-fold increased risk of developing the condition.
- supports: COVID-19, loneliness, social isolation and risk of dementia in older people: a systematic … (International journal of psychiatry in clinical practice 2022) · cited 111x in the literature
"Results of the meta-analysis show that in older people, the risk of developing dementia because of the impact of prolonged loneliness and social isolation is about 49 to 60% [HR/HR = 1.49; CI 95 =1.37-1.61] higher than in those who are not lonely and socially isolated." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Potentially Modifiable Risk Factors for Dementia and Mild Cognitive Impairment: An Umbrell… (Dementia and geriatric cognitive disorders 2024) · cited 90x in the literature
"We identified fourteen broadly defined modifiable risk factors that were significantly associated with these disorders: alcohol consumption, body weight, depression, diabetes mellitus, diet, hypertension, less education, physical inactivity, sensory loss, sleep disturbance, smoking, social isolation, traumatic brain injury, and vitamin D deficiency. All 14 factors were associated with the risk of major NCD" (abstract, results, passage verified)
pubmedfull study (doi)
Social isolation is a trigger for depression.
"it's clearly a trigger for depression." (said at 0:17:13)
Extensive epidemiological and longitudinal evidence supports the claim that social isolation (and the related experience of loneliness) is a significant risk factor and precipitating trigger for the onset of depressive symptoms and major depression. A meta-analysis examining social isolation in older adults (PMID: 41578462) identified a 60% increased likelihood of depressive symptoms (pooled OR = 1.60, 95% CI: 1.39–1.84). Similarly, a systematic review and meta-analysis of prospective cohort studies (PMID: 35583561) evaluating the new onset of mental health disorders found that baseline social disconnection/loneliness more than doubled the adjusted risk of subsequent incident depression (pooled adjusted OR = 2.33, 95% CI: 1.62–3.34).
A breathing pattern of 3-4 seconds inhalation and 6-8 seconds exhalation triggers a parasympathetic nervous system response.
"we had worked on this very specific breathing pattern. It's been found to trigger a parasympathetic response, which is basically three or four seconds in, so take a deep breath, and then six to eight seconds out." (said at 0:21:56)
Paced slow breathing with prolonged exhalation (typically a 1:2 inhalation-to-exhalation ratio, such as 3-4 seconds inhaling and 6-8 seconds exhaling, corresponding to roughly 6 breaths per minute) is well-documented to enhance vagally mediated heart rate variability (HRV) and activate parasympathetic nervous system activity. Experimental studies and randomized trials demonstrate that prolonging the exhalation phase relative to inhalation increases high-frequency heart rate variability (HF-HRV) and the root mean square of successive differences (RMSSD), established physiological markers of cardiac vagal tone.
Dr. Amen scanned and evaluated 300 NFL players in a study starting in 2009 and found high levels of brain damage.
"I did the big NFL study starting in 2009. We scanned and treated 300 NFL players: high levels of damage." (said at 0:24:15)
Dr. Amen and colleagues initiated an ongoing longitudinal study in 2009 evaluating active and retired NFL players using SPECT perfusion neuroimaging and clinical evaluations. Published findings from this cohort reported significant hypoperfusion across 36 brain regions consistent with traumatic brain injury in 161 NFL players compared to 124 healthy controls, and a pilot open-label intervention study evaluated and treated 30 players. The certainty is low due to observational and open-label study designs.
Dr. David Smith founded the Haight Ashbury Free Clinic.
"David Smith, who's founder of the Haight Ashbury Free Clinic and really thought of as the father of addiction medicine in the United States" (said at 0:29:10)
Historical records and scholarly literature document that Dr. David E. Smith founded the Haight Ashbury Free Medical Clinic (HAFMC) in San Francisco in 1967. The clinic was established during the counterculture movement to provide free, nonjudgmental healthcare and addiction treatment to underserved populations, cementing Smith's role as a pioneer in the development of modern addiction medicine.
Brain damage from head trauma increases the risk of addictive behavior and loss of behavioral control.
"You damage your brain, you're more likely to have behavior that gets out of control." (said at 0:29:45)
Traumatic brain injury (TBI) is well-documented in clinical neurotrauma and psychiatric literature to elevate the risk of behavioral dyscontrol, impulsivity, disinhibition, aggression, and addictive behaviors (such as substance use disorders and problem gambling). Systematic reviews and meta-analyses estimate that substantial proportions of TBI patients develop post-injury personality changes characterized by poor impulse control, emotional lability, and behavioral disinhibition.
- supports: Agitation, aggression, and disinhibition syndromes after traumatic brain injury. (NeuroRehabilitation 2002) · cited 146x in the literature
"Traumatic brain injury (TBI) is frequently complicated by disinhibition and aggression. These often profound changes in personality, present obstacles to rehabilitative treatments and community reentry. Syndromal presentations may involve a loss of impulse control, spontaneous aggression, and dysphoric bipolar states." (abstract, results, passage verified)
pubmed - supports: Moderate to severe gambling problems and traumatic brain injury: A population-based study. (Psychiatry research 2019) · cited 19x in the literature
"Traumatic brain injury (TBI) is a common injury characterized by a change in brain function after an external blow to the head and is associated with substance abuse, psychological distress, risk-taking, and impulsivity." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Personality change after traumatic brain injury: a systematic review and meta-analysis. (Journal of neurology 2026)
"Personality change was defined inconsistently although common symptoms involved the emergence or increase of affective, behavioral, and social disturbances, including irritability, depression, emotional instability, anger outbursts, social withdrawal, anxiety, impulsivity, restlessness, aberrant motor behaviors, and aggression. The prevalence of secondary personality disorder was estimated as 29.1% (CIs 22.5% - 36.2%) and prevalence of broad personality change was 68.1% (CIs 53.4% - 81.2%)." (abstract, results, passage verified)
pubmedfull study (doi)
Frequent massive dopamine surges lead to desensitization in the nucleus accumbens, requiring higher stimulation to experience pleasure.
"dopamine is really important and it presses on the nucleus accumbens, but if you dump it, it presses too hard, just like fame. So think of Miley or Justin. They get all of this dopamine, well, it wears it out, and then they need more and more in order to feel anything at all." (said at 0:30:00)
Extensive neuroimaging and preclinical research supports the concept that repeated, supraphysiological dopamine release in the reward circuitry (including the nucleus accumbens) leads to neuroadaptive down-regulation. Human positron emission tomography (PET) studies demonstrate that chronic excessive stimulation blunts striatal dopamine release and decreases dopamine D2 receptor availability in the nucleus accumbens and dorsal striatum. These neuroadaptations reduce baseline sensitivity to everyday rewards and require increasingly potent stimuli to achieve equivalent dopamine signaling and subjective reward.
- supports: Addiction: beyond dopamine reward circuitry. (Proceedings of the National Academy of Sciences of the United States of America 2011) · cited 958x in the literature
"These studies have corroborated in humans the relevance of drug-induced fast DA increases in striatum [including nucleus accumbens (NAc)] in their rewarding effects but have unexpectedly shown that in addicted subjects, drug-induced DA increases (as well as their subjective reinforcing effects) are markedly blunted compared with controls... Also, whether tested during early or protracted withdrawal, addicted subjects show lower levels of D2 receptors in striatum (including NAc)..." (abstract, passage verified)
pubmedfull study (doi) - supports: The Brain on Drugs: From Reward to Addiction. (Cell 2015) · cited 1311x in the literature
"Drugs of abuse exert their initial reinforcing effects by triggering supraphysiologic surges of dopamine in the nucleus accumbens that activate the direct striatal pathway via D1 receptors and inhibit the indirect striato-cortical pathway via D2 receptors. Repeated drug administration triggers neuroplastic changes in glutamatergic inputs to the striatum and midbrain dopamine neurons, enhancing the brain's reactivity to drug cues, reducing the sensitivity to non-drug rewards, weakening self-regulation, and increasing the sensitivity to stressful stimuli and dysphoria." (abstract, passage verified)
pubmedfull study (doi)
Dopamine acts directly on the nucleus accumbens in the brain.
"So dopamine is really important and it presses on the nucleus accumbens, but if you dump it, it presses too hard, just like fame." (said at 0:30:27)
The mesolimbic dopaminergic pathway is a well-established neural circuit in which dopamine-producing neurons projecting from the ventral tegmental area directly innervate the nucleus accumbens. Dopamine released into the nucleus accumbens binds to local dopamine receptors (such as D1 and D2 receptors) to regulate intracellular signaling, synaptic plasticity, reward processing, and motivated behavior.
- supports: Nucleus Accumbens as a Novel Target for Deep Brain Stimulation in the Treatment of Addicti… (Neurology India 2019) · cited 18x in the literature
"The three stages of the addiction cycle are known to be mediated by dopaminergic pathways located in the mesolimbic dopamine system with connections to dorsal striatum, extended amygdala, cingulate gyrus, orbitofrontal cortex, prefrontal cortex, and ventral tegmental area. Recent advanced neuroimaging in humans and several animal studies demonstrated NA to be a vital anatomical area modulating this network." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Phosphorylation Signals Downstream of Dopamine Receptors in Emotional Behaviors: Associati… (International journal of molecular sciences 2022) · cited 13x in the literature
"Dopamine regulates emotional behaviors, including rewarding and aversive behaviors, through the mesolimbic dopaminergic pathway, which projects dopamine neurons from the ventral tegmental area to the nucleus accumbens (NAc)." (abstract, background, passage verified)
pubmedfull study (doi)
Chronically high blood sugar damages blood vessels, causing them to lose flexibility and become brittle and prone to breaking.
"Which is an emergency, because when your blood sugar is chronically high, it erodes your blood vessels, making them more likely to lose their flexibility, be brittle, and more likely to break." (said at 0:55:35)
Published literature confirms that chronic hyperglycemia drives vascular damage through multiple well-characterized pathways, including endothelial dysfunction, oxidative stress, advanced glycation end-product (AGE) cross-linking of extracellular matrix proteins, and vascular smooth muscle calcification. These pathophysiological alterations directly result in loss of arterial compliance (increased arterial stiffness) and structural vessel wall fragility, which predisposes to microvascular and macrovascular injury.
- supports: Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus… (Drugs 2005) · cited 84x in the literature
"Hyperglycaemia also contributes to accelerated arterial stiffening by increasing formation of advanced glycation end-products (AGEs), which alter vessel wall structure and function." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization. (Arteriosclerosis, thrombosis, and vascular biology 2020) · cited 262x in the literature
"In relation to diabetes mellitus, the regulation of both hyperglycemia and increased protein glycosylation, by AGEs (advanced glycation end products) and O -linked β-N-acetylglucosamine modification, and its role in enhancing intracellular pathophysiological signaling that promotes osteogenic differentiation and calcification of vascular smooth muscle cells are discussed." (abstract, results, passage verified)
pubmedfull study (doi) - supports: From diabetic foot to dementia: A neurovascular continuum linking systemic diabetic vascul… (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026)
"Diabetes induces widespread vascular alterations, including endothelial dysfunction, arterial stiffening, oxidative stress, and chronic low-grade inflammation [3,4]... Increased arterial stiffness may impair the Windkessel effect and facilitate the transmission of excessive pulsatile energy into fragile cerebral perforating arteries, thereby promoting microvascular injury and white matter damage" (abstract, results)
pubmedfull study (doi)
In the United States population, 72% are overweight, 42% are obese, and 50% are diabetic or pre-diabetic according to published JAMA data.
"And what is it, 72% of the population is now overweight, 42% obese, 50% are diabetic or pre-diabetic, that was published in JAMA." (said at 1:00:15)
Published nationally representative epidemiological data (primarily from the National Health and Nutrition Examination Survey [NHANES], frequently reported in JAMA and CDC publications) support these figures for US adults. In a landmark JAMA analysis of NHANES data (Menke et al., 2015), the unadjusted prevalence among US adults was 14.3% for total diabetes (diagnosed and undiagnosed) and 38.0% for prediabetes, totaling 52.3% (over 50%) with diabetes or prediabetes. Similarly, NHANES surveillance data show that approximately 71% to 73% of US adults are classified as overweight or obese (BMI ≥25 kg/m²), with adult obesity prevalence (BMI ≥30 kg/m²) reaching approximately 42.4%.
- supports: Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. (JAMA 2015) · cited 2412x in the literature
"In the overall 2011-2012 population, the unadjusted prevalence (using the hemoglobin A1c, FPG, or 2-hour PG definitions for diabetes and prediabetes) was 14.3% (95% CI, 12.2%-16.8%) for total diabetes, 9.1% (95% CI, 7.8%-10.6%) for diagnosed diabetes, 5.2% (95% CI, 4.0%-6.9%) for undiagnosed diabetes, and 38.0% (95% CI, 34.7%-41.3%) for prediabetes" (abstract, results, passage verified)
pubmedfull study (doi)
Adipose tissue converts testosterone into forms of estrogen.
"If you're overweight, your hormone balance isn't right because fat takes healthy testosterone, turns it into unhealthy forms of estrogen." (said at 1:00:39)
Adipose tissue expresses the enzyme aromatase (CYP19A1), which catalyzes the peripheral conversion of androgens, such as testosterone and androstenedione, into estrogens (primarily 17β-estradiol and estrone). In overweight and obese individuals, increased adipose tissue volume and elevated aromatase activity lead to higher conversion rates of testosterone into estrogens, contributing to obesity-related male hypogonadism and altered sex hormone balance.
- supports: Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism. (International journal of molecular sciences 2022) · cited 124x in the literature
"Several mechanisms may indeed negatively affect the hypothalamic-pituitary-gonadal health, such as higher testosterone conversion to estradiol by aromatase activity in the adipose tissue, increased ROS production, and the release of several endocrine molecules affecting the hypothalamus-pituitary-testis axis" (abstract, passage verified)
pubmedfull study (doi) - supports: Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obe… (The Journal of clinical endocrinology and metabolism 2025) · cited 34x in the literature
"Aromatase (ARO) converts testosterone into E2, and this occurs mainly in adipose tissue in men... Elevated ARO in SAT was found in obese men, and this was linked to insulin resistance and glycemia, supporting the idea that local estrogen production contributes to metabolic dysregulation." (abstract, results and conclusions)
pubmedfull study (doi) - supports: Metabolic impact of endogenously produced estrogens by adipose tissue in females and males… (Frontiers in endocrinology 2025) · cited 22x in the literature
"Estrogens, comprised primarily of estrone (E1) and estradiol (E2) within WAT, are biosynthesized from circulating androgens androstenedione (A4) and testosterone (T) by aromatase (CYP19A1), which is highly expressed in human and mouse adipose tissue." (abstract, passage verified)
pubmedfull study (doi)
A published study by Daniel Amen examining 35,000 brain scans found a linear correlation where higher body weight was associated with decreased blood flow across virtually every brain region.
"I published a study last year on 35,000 scans showing there was, David, a linear correlation: as your weight went up, blood flow to virtually every area of your brain went down." (said at 1:00:52)
A 2020 cross-sectional study by Daniel Amen and colleagues analyzed 35,442 brain SPECT scans from 17,721 adults in a psychiatric clinic cohort across different BMI categories. The study reported that higher BMI was significantly correlated with decreased cerebral blood flow (hypoperfusion) during both resting and concentration tasks across virtually all 128 brain regions examined. Because this was a retrospective, cross-sectional observational study in a self-selected clinical population, it demonstrates association rather than direct causation.
Pre-hypertension is associated with brain atrophy.
"Even being pre-hypertensive is associated with brain atrophy." (said at 0:08:55)
Observational neuroimaging research shows that prehypertensive or elevated blood pressure (defined as systolic blood pressure of 120–139 mm Hg or diastolic blood pressure of 80–89 mm Hg) is associated with reduced regional gray matter volume and lower total cerebral brain volume, even in young to middle-aged adults without clinical hypertension.
Hyperbaric oxygen therapy significantly improves cerebral blood flow in military personnel who suffered blast injuries.
"I published a study in the Journal of Neurotrauma on soldiers who had blast injuries: significant improvements in blood flow with hyperbaric oxygen." (said at 0:12:25)
A preliminary phase I clinical trial published in the Journal of Neurotrauma evaluated 16 military personnel with blast-induced mild-to-moderate traumatic brain injury/post-concussion syndrome and post-traumatic stress disorder treated with 40 sessions of 1.5 ATA hyperbaric oxygen therapy (HBOT). Single-photon emission computed tomography (SPECT) statistical parametric mapping analysis showed diffuse, statistically significant improvements in regional cerebral blood flow after 1 and 40 sessions. However, the evidence certainty is very low because the study was a small, open-label, uncontrolled pilot trial without a sham control group.
Meditation increases blood flow and neural activity in the frontal lobes.
"And meditation, which actually fooled us because, you know, you'd think meditation, it would calm everything down in the brain. Absolutely doesn't do that, especially in your frontal lobes; it increases blood flow and activity." (said at 0:12:38)
Functional neuroimaging and cerebral blood flow (CBF) studies demonstrate that meditation engages and increases neural activation and blood flow in frontal lobe regions, particularly the prefrontal cortex and anterior cingulate, rather than inducing generalized cerebral deactivation. Single photon emission computed tomography (SPECT) studies show significant increases in regional cerebral blood flow in the dorsolateral prefrontal cortex, orbital frontal cortex, and cingulate gyrus during meditation, as well as higher baseline prefrontal CBF in experienced meditators. Coordinate-based fMRI meta-analyses similarly confirm consistent activation of fronto-medial and prefrontal networks during meditative practices, reflecting active attentional and executive control processes.
- supports: The measurement of regional cerebral blood flow during the complex cognitive task of medit… (Psychiatry research 2001) · cited 495x in the literature
"Significantly increased rCBF (P<0.05) was observed in the cingulate gyrus, inferior and orbital frontal cortex, dorsolateral prefrontal cortex (DLPFC), and thalamus. The change in rCBF in the left DLPFC correlated negatively (P<0.05) with that in the left superior parietal lobe. Increased frontal rCBF may reflect focused concentration and thalamic increases overall increased cortical activity during meditation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Cerebral blood flow differences between long-term meditators and non-meditators. (Consciousness and cognition 2010) · cited 107x in the literature
"The CBF of long-term meditators was significantly higher (p<.05) compared to non-meditators in the prefrontal cortex, parietal cortex, thalamus, putamen, caudate, and midbrain." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A neurocognitive model of meditation based on activation likelihood estimation (ALE) meta-… (Consciousness and cognition 2012) · cited 90x in the literature
"To test this hypothesis, we conducted a quantitative meta-analysis based on activation likelihood estimation (ALE) of 10 neuroimaging studies (91 subjects) on different meditative techniques to evidence the core cortical network subserving meditation. We showed activation of basal ganglia (caudate body), limbic system (enthorinal cortex) and medial prefrontal cortex (MPFC)." (abstract, results, passage verified)
pubmedfull study (doi)
Brain SPECT imaging studies demonstrate that Ginkgo biloba and vinpocetine increase cerebral blood flow.
"And from a supplement standpoint, I'm a huge fan of Ginkgo and vinpocetine. Brain SPECT imaging studies on both of them showing that they increase blood flow." (said at 0:12:58)
Published neuroimaging studies using single photon emission computed tomography (SPECT) have documented increases in regional cerebral blood flow or perfusion following administration of Ginkgo biloba and vinpocetine. A double-blind, randomized trial of Ginkgo biloba in older men found improved cerebral perfusion on SPECT alongside reduced blood viscosity. Similarly, clinical investigations and reviews evaluating vinpocetine (Cavinton) in patients with chronic cerebrovascular insufficiency report enhanced cerebral hemoperfusion and metabolism measured via SPECT and related imaging modalities.
- supports: Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using Gin… (Pharmacopsychiatry 2003) · cited 74x in the literature
"Evaluation was based on a number of neuropsychological tests in an attempt to cover the largest possible number of functions including Single Photon Emission Computer Tomography (SPECT) and measures of blood viscosity. The study was run on a double-blind basis with placebo and Ginkgo biloba groups evaluated over a period of 8 months. After treatment, the experimental group showed a reduction in blood viscosity, improved cerebral perfusion in specific areas and improved global cognitive functioning." (abstract, results, passage verified)
pubmedfull study (doi) - supports: [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studi… (Orvosi hetilap 2007) · cited 40x in the literature
"In chronic cerebrovascular patients after single dose and long-term vinpocetine therapy, PET, TCD, SPECT and NIRS examinations showed increasing perfusion and elevated glucose and O 2 consumption of the examined areas, furthermore significant improvement of the rheologic factors was detected." (abstract, results, passage verified)
pubmedfull study (doi)
A UK study of 88,000 people found that individuals playing racquet sports had increased longevity compared to other sports participants, whereas running showed no mortality difference.
"But there was a study last year on 88,000 people in the United Kingdom: the people who played racquet sports lived longer than everyone else. So football players lived shorter than everyone else, soccer players shorter, runners actually didn't make a difference, swimmers longer, but it was tennis, table tennis, badminton, squash, racquetball that they lived longer." (said at 0:13:28)
A 2017 pooled cohort study of 80,306 British adults published in the British Journal of Sports Medicine examined the associations of six sport types with mortality. Participation in racquet sports (badminton, tennis, squash) had the strongest inverse association with all-cause mortality (hazard ratio 0.53, 95% CI 0.40 to 0.69) compared to non-participation, followed by swimming, aerobics, and cycling. In contrast, participation in running/jogging and football showed no statistically significant reduction in all-cause or cardiovascular mortality after multivariable adjustment. Note that while football players did not show a survival advantage in this cohort, they did not have a statistically significant increase in mortality ('lived shorter'). As an observational study, residual confounding and reverse causation cannot be ruled out.
Damage to the left frontal lobe turns off or suppresses activity in the right cerebellum due to cross-cerebellar diaschisis.
"If you damage the left frontal lobe, it actually turns off your right cerebellum, and we can see it beautifully on SPECT." (said at 0:14:10)
The speaker accurately describes crossed cerebellar diaschisis (CCD), a well-characterized neuroanatomical phenomenon in which supratentorial injury (such as ischemic damage or lesions in the frontal or motor cortex) leads to a functional depression of blood flow and metabolism in the contralateral cerebellar hemisphere via disruption of the cortico-ponto-cerebellar pathway. This reduction in contralateral cerebellar perfusion and metabolism is routinely detected and visualized using single-photon emission computed tomography (SPECT) as well as PET imaging.
- supports: Crossed cerebellar hypoperfusion in hyperacute ischemic stroke. (Journal of the neurological sciences 2004) · cited 28x in the literature
"In chronic stage of cerebral hemispheric infarction, contralateral cerebellar blood flow and metabolism are depressed, which is known as crossed cerebellar diaschisis (CCD)... Single photon emission computed tomography was performed in 21 patients... The side-to-side ratio of cerebellar blood flow ipsilateral to that contralateral to cerebral infarct was significantly increased compared with that in normal control (P<0.001), indicating that contralateral cerebellar blood flow was significantly depressed." (abstract, results)
pubmedfull study (doi) - supports: Prevalence and Imaging Correlates of Cerebral Diaschisis After Ischemic Stroke: A Systemat… (Brain sciences 2025) · cited 4x in the literature
"Diaschisis, reduced neural activity, perfusion, and metabolism in structurally intact but anatomically connected regions, is a network-level consequence of focal brain injury... Detection varied primarily by imaging modality: ASL MRI (67%) and PET (58%) showed the highest sensitivity; SPECT (53%) and CTP (49%) were intermediate" (abstract, results)
pubmedfull study (doi) - supports: Crossed cerebellar diaschisis: the role of motor and premotor areas in functional connecti… (Journal of neuroimaging : official journal of the American Society of Neuroimaging 1999) · cited 20x in the literature
"The CCD rate was calculated from side-to-side cerebellar count differences on 123I-IMP single-photon emission computerized tomography images... multiple stepwise regression analysis using the theory of quantification I, in which significant correlation only between CCD and the necrotic density (score 2) in motor and premotor areas were demonstrated (r = 0.515, p = < 0.05)." (abstract, results)
pubmedfull study (doi)
Working in an occupation that does not require new learning is associated with an increased risk of memory problems.
"If you're in a job that does not require new learning, you actually have a higher risk of memory problems." (said at 0:16:09)
Large prospective cohort studies demonstrate that occupations with low cognitive stimulation and low demand for novel, non-routine tasks are associated with an increased risk of subsequent cognitive impairment and dementia. In the HUNT4 70+ longitudinal cohort (n = 7,003), individuals working in jobs characterized by high routine task intensity (and low cognitive demands) during midlife had a significantly higher risk of developing mild cognitive impairment (relative risk ratio 1.74, 95% CI 1.41–2.14) and dementia (RRR 1.37, 95% CI 1.01–1.86) compared to those in cognitively demanding roles. Similarly, an individual-participant meta-analysis of over 107,000 adults across Europe and the US found that individuals in low cognitive stimulation jobs had a significantly higher risk of dementia compared to those with high cognitive stimulation at work (adjusted HR 0.82 for high stimulation, 95% CI 0.68–0.98).
- supports: Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analy… (BMJ (Clinical research ed.) 2021) · cited 99x in the literature
"The risk of dementia in old age was found to be lower in people with cognitively stimulating jobs than in those with non-stimulating jobs." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and D… (Neurology 2024) · cited 31x in the literature
"Participants in the high RTI group had a higher risk of MCI (RRR 1.74, 95% CI 1.41-2.14) and dementia (RRR 1.37, 95% CI 1.01-1.86), after adjusting for age, sex, and education compared with participants in the low RTI group." (abstract, results, passage verified)
pubmedfull study (doi)
A study conducted in Baltimore found that volunteering increased hippocampal volume in older adults.
"And there's a study from Baltimore that found volunteering actually increased the size of the hippocampus." (said at 0:16:44)
A randomized controlled trial nested within the Baltimore Experience Corps Trial (an intergenerational volunteering program for older adults in public elementary schools) evaluated changes in brain volume over 2 years in 111 older adults. Participants in the volunteering arm demonstrated increases in cortical and hippocampal volumes compared to the typical age-related volume loss observed in control participants; these increases reached statistical significance in men (0.7% to 1.6% increase) and showed modest gains (0.3% to 0.54%) relative to control declines in women.
Elevated C-reactive protein levels correlate with a higher incidence of depression.
"So very few people actually know that, but in the studies looking at C-reactive protein, there is a higher incidence of depression in people who have high C-reactive protein." (said at 0:18:21)
Prospective longitudinal studies and meta-analyses support the association between elevated baseline C-reactive protein (CRP) levels and a higher subsequent risk or incidence of depressive symptoms. A systematic review and meta-analysis of prospective community studies (PMID: 32807846) confirmed that baseline CRP elevation is associated with future depressive symptoms in both unadjusted and adjusted analyses, although the effect size is modest and significantly attenuated after controlling for confounding factors (such as BMI, health status, and age).
A lower omega-3 index is associated with an increased risk of depression.
"Also, people who have a low omega-3 index, which is a study helped to be designed by Bill Harris from OmegaQuant—I think he's at the University of South Dakota. The lower your omega-3 index, the higher your risk for depression." (said at 0:18:54)
The claim accurately reflects epidemiological and clinical evidence linking a lower omega-3 index (the sum of eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA] in red blood cell membranes) with an increased risk or severity of depressive symptoms.
Multiple observational, case-control, and cohort studies demonstrate that lower red blood cell omega-3 fatty acid levels are inversely correlated with depression severity and major depressive disorder. For example, acute coronary syndrome patients with low omega-3 index values exhibit higher depressive symptom scores (PMID: 18842751), lower omega-3 index levels during pregnancy predict higher postpartum depressive symptoms (PMID: 23844041), and depressed adolescents show a significantly reduced omega-3 index compared to controls (PMID: 22464051). Systematic review evidence synthesising psychiatric research also identifies low omega-3 index status as a significant risk factor across major depressive disorder and postpartum depression (PMID: 37575565).
Because the underlying data primarily stem from observational and case-control studies subject to potential residual confounding, the certainty of evidence for a causal risk relationship is moderate.
- supports: Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatt… (Psychosomatic medicine 2008) · cited 52x in the literature
"There was a significant inverse relationship between the n-3 index and depressive symptoms (PHQ) in the fully adjusted model (p = .034)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Red blood cell fatty acids are associated with depression in a case-control study of adole… (Prostaglandins, leukotrienes, and essential fatty acids 2012) · cited 68x in the literature
"These findings support the hypothesis that adolescent depression is associated with a perturbed RBC fatty acid pattern which includes a reduced omega-3 index." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depress… (PloS one 2013) · cited 115x in the literature
"In this study population, a low omega-3 index in late pregnancy was associated with higher depression score three months postpartum." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Omega-3 index as risk factor in psychiatric diseases: a narrative review. (Frontiers in psychiatry 2023) · cited 14x in the literature
"The published evidence is compelling enough to suggest omega-3 index as a risk factor for some psychiatric diseases, specifically, major depression, postpartum depression, psychosis, and dementia." (abstract, conclusions, passage verified)
pubmedfull study (doi)
For psychiatric conditions like ADHD and depression, EPA is the beneficial omega-3 fatty acid, while DHA is ineffective.
"And people think of EPA for the heart and DHA for the brain, but I don't like people thinking like that, because people who have ADHD or depression, DHA is not helpful at all; it's EPA that seems to be the most helpful." (said at 0:27:20)
Multiple meta-analyses of randomized controlled trials confirm that eicosapentaenoic acid (EPA), rather than docosahexaenoic acid (DHA), is the primary driver of clinical efficacy in both depression and ADHD. In major depressive disorder, EPA-predominant formulations (typically containing ≥60% EPA) consistently show significant antidepressant benefits over placebo, whereas DHA-pure or DHA-predominant formulas fail to demonstrate efficacy. Similarly, meta-analytic evidence in ADHD indicates that symptom improvement with omega-3 supplementation is specifically correlated with higher EPA doses rather than DHA.
- supports: Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depressi… (The Journal of clinical psychiatry 2011) · cited 416x in the literature
"Supplements with EPA ≥ 60% showed benefit on standardized mean depression scores (effect size = 0.532; 95% CI, 0.277-0.733; t = 4.195; P < .001) versus supplements with EPA < 60% (effect size = -0.026; 95% CI, -0.200 to 0.148; t = -0.316; P = .756)... Supplements with EPA < 60% were ineffective." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hy… (Journal of the American Academy of Child and Adolescent Psychiatry 2011) · cited 414x in the literature
"Omega-3 fatty acid supplementation demonstrated a small but significant effect in improving ADHD symptoms. Eicosapentaenoic acid dose within supplements was significantly correlated with supplement efficacy." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Efficacy of omega-3 PUFAs in depression: A meta-analysis. (Translational psychiatry 2019) · cited 417x in the literature
"Compared with placebo, EPA-pure (=100% EPA) and EPA-major formulations (≥60% EPA) demonstrated clinical benefits with an EPA dosage ≤1 g/d (SMD = -0.50, P = 0.003, and SMD = -1.03, P = 0.03, respectively), whereas DHA-pure and DHA-major formulations did not exhibit such benefits." (abstract, results, passage verified)
pubmedfull study (doi)
Eighty percent of retired NFL players treated with Dr. Amen's intervention program demonstrated cognitive improvement.
"This is what we used on our NFL players, and 80% of our players—we published this—80% of our players show improvement when we put them on this program" (said at 0:33:31)
The speaker accurately cites the findings from their published open-label clinical trial in 30 retired NFL players. In the study, retired players underwent an average of 6 months on a multi-component intervention (lifestyle changes, fish oil, and brain-directed dietary supplements) and demonstrated significant improvements across multiple cognitive domains on the MicroCog assessment (corrected for practice effects) and increased cerebral perfusion on brain SPECT. Because the study was a small, open-label, uncontrolled before-and-after case series, the certainty of evidence for the intervention's causal efficacy is very low.
Studies show that anesthesia is associated with decreased overall blood flow to the brain.
"there are a number of studies showing that anesthesia is associated with lower overall blood flow to the brain" (said at 0:36:00)
Multiple functional neuroimaging studies using PET and fMRI demonstrate that general anesthesia (such as propofol-induced anesthesia) significantly decreases global and regional cerebral blood flow (CBF), coupled with reductions in cerebral metabolic demand. Quantitative PET measurements in healthy volunteers show approximately 45% to 50% reductions in total CBF during surgical levels of anesthesia compared with the conscious awake baseline.
- supports: Regional cerebral blood flow and glucose metabolism during propofol anaesthesia in healthy… (Acta anaesthesiologica Scandinavica 2012) · cited 88x in the literature
"Compared with the conscious state, total CBF and GMR decreased during the anaesthetic state with 47% and 54%, respectively. In the white and grey matter, rCBF and rGMR were reduced by 37% and 49%, and by 45% and 57%, respectively. Propofol decreased rCBF in all brain structures by 46-55% (P ≤ 0.01) with highest significant decreases in the thalamus and parietal lobe." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Anesthetic effects of propofol in the healthy human brain: functional imaging evidence. (Journal of anesthesia 2015) · cited 57x in the literature
"In the unconscious state, propofol sharply reduces the regional glucose metabolism rate (rGMR) and regional cerebral blood flow (rCBF) in all brain regions, particularly in the thalamus." (abstract, results, passage verified)
pubmedfull study (doi)
A Finnish study found that taking saunas five to seven times a week was associated with a two-thirds lower risk of Alzheimer's disease compared to taking them once a week or not at all.
"Brand new study from Finland: people who take saunas five to seven times a week had two-thirds lower risk of Alzheimer's disease than people who were just taking it once a week or not taking them at all." (said at 0:38:12)
A prospective cohort study of 2,315 middle-aged Finnish men (the Kuopio Ischaemic Heart Disease study) followed for over 20 years found that men who took saunas 4 to 7 times per week had a 65% lower risk of Alzheimer's disease (hazard ratio 0.35, 95% CI: 0.14-0.90) and a 66% lower risk of dementia (hazard ratio 0.34, 95% CI: 0.16-0.71) compared to men who had only 1 sauna session per week. As this is observational cohort data in a male-only Finnish population, evidence certainty is graded as low.
- supports: Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged… (Age and ageing 2017) · cited 134x in the literature
"In analysis adjusted for age, alcohol consumption, body mass index, systolic blood pressure, smoking status, Type 2 diabetes, previous myocardial infarction, resting heart rate and serum low-density lipoprotein cholesterol, compared with men with only 1 sauna bathing session per week, the HR for dementia was 0.78 (95% CI: 0.57-1.06) for 2-3 sauna bathing sessions per week and 0.34 (95% CI: 0.16-0.71) for 4-7 sauna bathing sessions per week. The corresponding HRs for Alzheimer's disease were 0.80 (95% CI: 0.53-1.20) and 0.35 (95% CI: 0.14-0.90)." (abstract, results, passage verified)
pubmedfull study (doi)
Exercise is equally effective as antidepressants in head-to-head studies for depression.
"Head-to-head against antidepressants, exercise is equally effective for depression." (said at 0:42:57)
Systematic reviews and network meta-analyses of randomised controlled trials comparing exercise interventions directly against antidepressant medications (pharmacotherapy) find comparable reductions in depressive symptom severity, with no statistically significant differences in effectiveness between the two modalities for non-severe or major depression. However, study authors note that exercise interventions often suffer from higher dropout rates than pharmacological treatments and that many trials have methodological limitations such as lack of participant blinding.
- supports: Comparative effectiveness of exercise, antidepressants and their combination in treating n… (British journal of sports medicine 2022) · cited 114x in the literature
"There were no differences in treatment effectiveness among the three main interventions (exercise vs antidepressants: standardised mean differences, SMD, -0.12; 95% CI -0.33 to 0.10, combination versus exercise: SMD, 0.00; 95% CI -0.33 to 0.33, combination vs antidepressants: SMD, -0.12; 95% CI -0.40 to 0.16), although all treatments were more beneficial than controls." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of exercise for depression: systematic review and network meta-analysis of randomis… (BMJ (Clinical research ed.) 2024) · cited 597x in the literature
"Exercise is an effective treatment for depression, with walking or jogging, yoga, and strength training more effective than other exercises, particularly when intense... These forms of exercise could be considered alongside psychotherapy and antidepressants as core treatments for depression." (abstract, conclusions)
pubmedfull study (doi)
Cognitive restructuring techniques are equally effective as antidepressants head-to-head.
"Head-to-head against antidepressants, learning how to not believe every stupid thought you have is equally effective as antidepressants." (said at 0:43:08)
Large systematic reviews and meta-analyses of randomized controlled trials demonstrate that cognitive behavioral therapy (CBT), which centers on cognitive restructuring (identifying and modifying maladaptive or automatic negative thoughts), demonstrates comparable efficacy to antidepressant medications in the acute treatment of depression. Furthermore, CBT shows advantages over pharmacotherapy at longer-term follow-up (6 to 12 months) due to enduring skills and lower relapse rates.
- supports: A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their com… (World psychiatry : official journal of the World Psychiatric Association (WPA) 2020) · cited 547x in the literature
"No significant difference was found between psychotherapy alone and pharmacotherapy alone (RR=0.99; 95% CI: 0.92-1.08). Similar results were found for remission." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapie… (World psychiatry : official journal of the World Psychiatric Association (WPA) 2023) · cited 341x in the literature
"The effects of CBT did not differ significantly from those of pharmacotherapies at the short term, but were significantly larger at 6-12 month follow-up (g=0.34; 95% CI: 0.09-0.58), although the number of trials was small, and the difference was not significant in all sensitivity analyses." (abstract, results, passage verified)
pubmedfull study (doi)
A Harvard study found that 52% of individuals with untreated ADHD have substance abuse issues.
"52% according to one study from Harvard have problems with substance abuse" (said at 0:45:45)
A landmark longitudinal study from Harvard Medical School / Massachusetts General Hospital (Biederman et al., 1999) and related cohort studies from the same group evaluated substance use disorder (SUD) rates among individuals with ADHD. In longitudinal follow-ups and adult cohorts, untreated ADHD was associated with a marked increase in substance use disorders (with lifetime prevalence around 52% to 75% in untreated/clinical adult cohorts, compared to significantly lower rates in medicated individuals and controls).
Having asthma increases the risk of Alzheimer's disease by 20%.
"And autoimmune disorders increase your risk of Alzheimer's disease, even simple ones like asthma. If you have asthma, it increases your risk 20%." (said at 0:49:20)
Large observational studies support the claim that asthma is associated with an approximately 20% increase in the risk of Alzheimer's disease. A 2024 nationwide Medicare cohort study of over 5.4 million beneficiaries found that individuals with asthma had a 20% to 33% higher 2-year incidence of Alzheimer's disease (matched odds ratio 1.20, 95% CI 1.17–1.24). A 2025 meta-analysis similarly identified elevated risks of cognitive decline and dementia among asthma patients. Notably, these findings reflect observational associations rather than proven direct causation, and asthma is medically classified as a chronic inflammatory/allergic airway disease rather than a classic autoimmune disorder.
- supports: Alzheimer incidence and prevalence with and without asthma: A Medicare cohort study. (The Journal of allergy and clinical immunology 2024) · cited 9x in the literature
"Multivariable models showed that asthma had greater odds of 2-year AD incidence (adjusted odds ratio, 1.33 [95% CI, 1.29-1.36]; matched 1.2 [95% CI, 1.17-1.24]) and prevalence (adjusted odds ratio, 1.48 [95% CI, 1.47-1.50]; matched 1.25 [95% CI, 1.22-1.27]). Asthma was associated with 20% to 33% increased 2-year incidence and 25% to 48% increased prevalence of claims-based AD in this nationally representative US sample." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Prevalence and risk of cognitive impairment among patients with asthma: A systematic revie… (Brain and behavior 2025) · cited 4x in the literature
"The analysis also revealed an increased hazard ratio of 1.47 (95% confidence interval [1.09; 1.84]) for cognitive impairment in patients with asthma compared to the control group (individuals without asthma)... The results underscored the substantial correlation between asthma and heightened risks of cognitive decline, dementia, and Alzheimer's disease." (abstract, results, passage verified)
pubmedfull study (doi)
Consuming a high dose of sugar causes an acute drop in testosterone levels of 25%.
"because if you get a sugar burst, it drops your testosterone by 25%." (said at 0:53:28)
Clinical studies show that acute ingestion of a glucose load causes a rapid, transient reduction in serum testosterone levels in men. In randomized experimental and crossover trials, acute oral glucose intake acutely suppresses total and basal testosterone secretion (typically by approximately 25%) in conjunction with reductions in pulsatile luteinizing hormone (LH) secretion.
Forty percent of Americans are obese.
"a brand-new study just came out last week: 40% of Americans are obese." (said at 0:53:46)
Nationally representative surveillance data from the National Health and Nutrition Examination Survey (NHANES) published by the CDC's National Center for Health Statistics found that the prevalence of obesity (BMI ≥ 30) among US adults was 40.3% during the August 2021–August 2023 cycle.
A brain imaging study by Cyrus Raji showed that overweight individuals had 4% less brain volume and obese individuals had 8% less brain volume compared to normal-weight individuals.
"He published the first study—I call it the dinosaur syndrome. He showed as a person's weight went up, the actual physical size of their brain went down. If you were overweight, you had 4% less brain volume, and your brain looked eight years older than healthy people. If you were obese, you had 8% less volume, and your brain looked 16 years older than the healthy weight population." (said at 0:53:58)
A 2010 neuroimaging study led by Cyrus Raji evaluated 94 cognitively normal elderly participants and examined brain tissue volume differences using tensor-based morphometry. The investigators found that higher BMI was associated with regional and global brain volume deficits, showing that overweight individuals had approximately 4% lower brain volume (corresponding to roughly 8 years of accelerated brain aging) and obese individuals had approximately 8% lower brain volume (corresponding to roughly 16 years of accelerated brain aging) compared to normal-weight individuals. Because this was a cross-sectional observational study with a relatively small sample size, the overall certainty of the evidence is low.
Sixty million Americans have sleep-related disorders.
"60 million Americans have sleep-related issues." (said at 0:56:58)
Standard epidemiological estimates from US public health authorities and published literature indicate that approximately 50 to 70 million Americans suffer from chronic sleep disorders or sleep-related issues, placing the speaker's figure of 60 million directly within the consensus range.
A Montreal Neurological Institute study using SPECT imaging showed significant perfusion decreases in the parietal lobes of individuals with sleep apnea.
"that's actually a published study published last year out of the Montreal Neurological Institute—in SPECT, significant decreases in the parietal lobes, the same area that dies early in Alzheimer's disease, with people who have sleep apnea." (said at 0:57:23)
A 2015 SPECT imaging study evaluating regional cerebral blood flow (rCBF) in 50 untreated obstructive sleep apnea (OSA) patients and 20 age-matched healthy controls found that individuals with severe sleep apnea had significant hypoperfusion in parietal regions—specifically the left parietal lobules and right precuneus—compared to controls. Mild and moderate sleep apnea groups did not show significant rCBF changes compared to controls. The study design is cross-sectional and observational with a modest sample size, placing the body of evidence at low certainty.
Dr. Amen published a study demonstrating that hypnotic trance decreases Parkinsonian tremors.
"And we ended up—that was one of my first published papers—that in a hypnotic trance, you can decrease parkinsonian tremors" (said at 0:59:38)
Dr. Daniel Amen co-authored an early 1990 paper reporting the reduction of severe Parkinsonian tremor during hypnosis, documented with polygraph/electromyography (EMG) and electroencephalography (EEG) recordings. Because the publication is an uncontrolled single-patient case report, it provides only very low-certainty evidence regarding the clinical efficacy of hypnosis for Parkinson's disease tremors.
Fact-checked episodes
Publications
- Examining comorbid and transdiagnostic depression clinical outcomes across anxiety, autism, attention deficit hyperactivity disorder (ADHD), bipolar disorder, depression, and schizotypal personality groups: a novel NeuroMark SPECT approach.medRxiv : the preprint server for health sciences 2026 · CEBM Level 4
- A Replicable NeuroMark Template for Whole-Brain SPECT Reveals Data-Driven Perfusion Networks and Their Alterations in Schizophrenia.Neuroinformatics 2026 · CEBM Level 4
- Classifying schizophrenia patients and healthy individuals: Whole brain SPECT functional connectivity using support vector machine classification.Neuroimage. Reports 2026 · CEBM Level 4
- Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder.JAMA psychiatry 2025 · CEBM Level 4
- Predicting Regional Cerebral Blood Flow Using Voxel-Wise Resting-State Functional MRI.Brain sciences 2025 · CEBM Level 4
- A multi-site 99m Tc-HMPAO SPECT study of cerebral blood flow in a community sample of patients with major depression.Translational psychiatry 2024 · CEBM Level 4
- Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.Frontiers in psychiatry 2024 · CEBM Level 4
- SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts.Frontiers in psychiatry 2021 · CEBM Level 4
- A New Way Forward: How Brain SPECT Imaging Can Improve Outcomes and Transform Mental Health Care Into Brain Health Care.Frontiers in psychiatry 2021 · CEBM Level 5
- Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults.Journal of Alzheimer's disease : JAD 2020 · CEBM Level 4
- Deficits in Regional Cerebral Blood Flow on Brain SPECT Predict Treatment Resistant Depression.Journal of Alzheimer's disease : JAD 2018 · CEBM Level 4
- Patterns of Regional Cerebral Blood Flow as a Function of Age Throughout the Lifespan.Journal of Alzheimer's disease : JAD 2018 · CEBM Level 4
- Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.Journal of Alzheimer's disease : JAD 2017 · CEBM Level 4
- Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.Journal of Alzheimer's disease : JAD 2017 · CEBM Level 4
- Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT.Journal of Alzheimer's disease : JAD 2017 · CEBM Level 4
- Gender-Based Cerebral Perfusion Differences in 46,034 Functional Neuroimaging Scans.Journal of Alzheimer's disease : JAD 2017 · CEBM Level 4
- Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.Journal of Alzheimer's disease : JAD 2016 · CEBM Level 4
- Functional neuroimaging with default mode network regions distinguishes PTSD from TBI in a military veteran population.Brain imaging and behavior 2015 · CEBM Level 4
- Functional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets.PloS one 2015 · CEBM Level 4
- Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.PloS one 2014 · CEBM Level 4
- Clinical utility of SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: a systematic review.PloS one 2014 · CEBM Level 1
- It's time to stop flying blind: how not looking at the brain leads to missed diagnoses, failed treatments, and dangerous behaviors.Alternative therapies in health and medicine 2013 · CEBM Level 4
- Multi-site six month outcome study of complex psychiatric patients evaluated with addition of brain SPECT imaging.Advances in mind-body medicine 2013 · CEBM Level 3
- Effects of brain-directed nutrients on cerebral blood flow and neuropsychological testing: a randomized, double-blind, placebo-controlled, crossover trial.Advances in mind-body medicine 2013 · CEBM Level 2
- Daniel Amen, MD: healing brain injury and damage from environmental toxins. Interviewed by Karen Burnett.Advances in mind-body medicine 2013 · CEBM Level 5
- A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder.Journal of neurotrauma 2012 · CEBM Level 4
- Daniel Amen, MD: the impact of brain imaging on psychiatry and treatment for improving brain health and function. Interview by Karen Burnett.Alternative therapies in health and medicine 2012 · CEBM Level 5
- The clinical utility of brain SPECT imaging in process addictions.Journal of psychoactive drugs 2012 · CEBM Level 5
- Specific ways brain SPECT imaging enhances clinical psychiatric practice.Journal of psychoactive drugs 2012 · CEBM Level 4
- Impact of playing American professional football on long-term brain function.The Journal of neuropsychiatry and clinical neurosciences 2011 · CEBM Level 4
- Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults.Obesity (Silver Spring, Md.) 2011 · CEBM Level 4
- Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation.Journal of psychoactive drugs 2011 · CEBM Level 3
- Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool.The open neuroimaging journal 2011 · CEBM Level 5
- Cerebral blood flow differences between long-term meditators and non-meditators.Consciousness and cognition 2010 · CEBM Level 4
- High resolution brain SPECT imaging in a clinical substance abuse practice.Journal of psychoactive drugs 2010 · CEBM Level 5
- Brain SPECT imaging in clinical practice.The American journal of psychiatry 2010 · CEBM Level 5
- Cerebral blood flow changes during chanting meditation.Nuclear medicine communications 2009 · CEBM Level 3
- A comparative analysis of completed suicide using high resolution brain SPECT imaging.The Journal of neuropsychiatry and clinical neurosciences 2009 · CEBM Level 4
- Omentum transposition surgery for patients with Alzheimer's disease: a case series.Neurological research 2008 · CEBM Level 4
- Predicting positive and negative treatment responses to stimulants with brain SPECT imaging.Journal of psychoactive drugs 2008 · CEBM Level 4
- Preliminary evidence differentiating ADHD using brain SPECT imaging in older patients.Journal of psychoactive drugs 2008 · CEBM Level 4
- An analysis of regional cerebral blood flow in impulsive murderers using single photon emission computed tomography.The Journal of neuropsychiatry and clinical neurosciences 2007 · CEBM Level 4
- High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD.The Journal of neuropsychiatry and clinical neurosciences 2005 · CEBM Level 4